Claro Advisors LLC Point Biopharma Global Inc. Transaction History

Claro Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$6.67 - $9.71 $1,240 - $1,806	-186 Reduced 1.67%	10,920 $72,000
Q2 2023 Aug 08, 2023	SELL	$6.86 - $10.86 $1,468 - $2,324	-214 Reduced 1.89%	11,106 $100,000
Q1 2023 Apr 17, 2023	SELL	$6.78 - $8.1 $3,390 - $4,050	-500 Reduced 4.23%	11,320 $82,000
Q4 2022 Feb 14, 2023	SELL	$5.72 - $9.78 $23,452 - $40,098	-4,100 Reduced 25.75%	11,820 $86,000
Q2 2022 Aug 12, 2022	SELL	$5.6 - $9.5 $41,328 - $70,110	-7,380 Reduced 31.67%	15,920 $108,000
Q4 2021 Feb 14, 2022	BUY	$4.83 - $9.75 $38,640 - $78,000	8,000 Added 52.29%	23,300 $130,000
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $113,526 - $172,278	15,300 New	15,300 $118,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Claro Advisors LLC with notifications on news.